| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology, and Genetics |
Department of Biomedical Sciences, Meharry Medical College, Nashville, Tennessee
Requests for reprints: Ifeanyi J. Arinze, Department of Biomedical Sciences, Meharry Medical College, 1005 Dr. David B. Todd, Jr. Boulevard, Nashville, TN 37208-3599. Phone: 615-327-6586; Fax: 615-327-6442; E-mail: iarinze{at}mmc.edu.
Valproic acid (VPA) is a widely used anticonvulsive agent that has profound antiproliferative effects in many cell types, as well as inductive effects on a number of genes. The mechanism of its gene-inducing effect has been reported to involve transcription factors, Sp1 and activator protein-1. Using two well-characterized antioxidant response element (ARE)driven gene promoters, i.e., mouse heme oxygenase-1 and human NAD(P)H:quinone oxidoreductase 1 genes as tools to monitor the transcriptional response to VPA, we show here that VPA-induced gene transcription was abrogated by antioxidants. With the human G
i2 gene promoter, which was previously used to establish the involvement of Sp1 in the transcriptional action of VPA, we found that VPA-induced gene transcription was also blocked by antioxidants. Mutation of the ARE (5'-TGACtggGC-3') in this promoter abrogated the transcriptional response to VPA. With such mutants, the NADPH oxidase inhibitor, diphenyleneiodonium, had no effect on VPA-induced transcription. In gel mobility shift assays, VPA-induced binding of nuclear proteins to a DNA probe containing the relevant ARE sequence in the G
i2 gene promoter was decreased in nuclear extracts from cells pretreated with antioxidants. Chromatin immunoprecipitation assays showed that the prototype redox-sensitive transcription factors, Nrf2, small Maf protein(s), and c-Fos, were recruited to this promoter in VPA-treated cells. Overall, this study reveals that the mechanism of the transcriptional response to VPA includes VPA-induced production of reactive oxygen species which induce the activation of redox-sensitive transcription factors that interact with the ARE. (Cancer Res 2006; 66(13): 6563-9)
This article has been cited by other articles:
![]() |
S. E. Wardell, O. R. Ilkayeva, H. L. Wieman, D. E. Frigo, J. C. Rathmell, C. B. Newgard, and D. P. McDonnell Glucose Metabolism as a Target of Histone Deacetylase Inhibitors Mol. Endocrinol., March 1, 2009; 23(3): 388 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Theodore, Y. Kawai, J. Yang, Y. Kleshchenko, S. P. Reddy, F. Villalta, and I. J. Arinze Multiple Nuclear Localization Signals Function in the Nuclear Import of the Transcription Factor Nrf2 J. Biol. Chem., April 4, 2008; 283(14): 8984 - 8994. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |